![PDF) Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial PDF) Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial](https://i1.rgstatic.net/publication/344140129_Intravenous_paracetamol_in_comparison_with_ibuprofen_for_the_treatment_of_patent_ductus_arteriosus_in_preterm_infants_a_randomized_controlled_trial/links/5f656315458515b7cf3ecc51/largepreview.png)
PDF) Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
![PDF) Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose PDF) Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose](https://www.researchgate.net/profile/Eric-Evene/publication/6466597/figure/fig2/AS:272047980937228@1441872701148/Mean-SD-plasma-concentrations-of-paracetamol-following-iv-administration-of-5g_Q320.jpg)
PDF) Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose
![PDF) Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol PDF) Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol](https://i1.rgstatic.net/publication/46036756_Effects_of_URB597_an_inhibitor_of_fatty_acid_amide_hydrolase_FAAH_on_analgesic_activity_of_paracetamol/links/626a53b805d79a3968a806a7/largepreview.png)